Skip to content
  • Sunday, 26 July 2026
  • 2:59 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Researchers at Chiba University Develop Viciazite Carbon Materials to Enable Low-Temperature Carbon Dioxide Capture and Reduce Industrial Emissions
Advanced Materials Science

Researchers at Chiba University Develop Viciazite Carbon Materials to Enable Low-Temperature Carbon Dioxide Capture and Reduce Industrial Emissions

Nila Kartika Wati Apr 13, 2026 0

The global effort to mitigate climate change has reached a critical juncture as atmospheric carbon dioxide (CO2) levels continue to…

Read More
Advanced Materials Science

Innovative Viciazite Materials Offer Low-Energy Pathway for Industrial Carbon Capture and Climate Mitigation

Nila Kartika Wati Apr 5, 2026 0

The global effort to mitigate the escalating effects of climate change has reached a critical juncture, with carbon capture and…

Read More
Advanced Materials Science

Breakthrough in Molecular Design of Viciazite Carbon Materials Enables Low-Temperature Carbon Dioxide Capture and Industrial Sustainability

Nila Kartika Wati Mar 29, 2026 0

The global imperative to mitigate climate change has centered on the reduction of atmospheric carbon dioxide (CO2), a primary driver…

Read More
TWiV 1288: Clinical Update with Dr. Daniel GriffinCortisol in Hair Reveals War’s Stressful Impact on Refugees, Outperforming SurveysAtomic Scale Barriers Could Derail the Future of 2D Semiconductor Technology According to TU Wien ResearchJazz Pharmaceuticals and AbCellera Forge Strategic Alliance to Pioneer Novel T-cell Engaging Antibodies for Gastrointestinal and Solid Tumors
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ